Ask any Specialty Pharma leader what they want in their next executive hire and you’ll hear familiar themes: “fresh thinking,” “diverse perspectives,” “ability to challenge the status quo.” Then the search progresses, and a strong candidate gets rejected with a vague line: “They’re great, but I’m not sure they’re a culture fit.” In many organizations, that is where diverse, high‑potential leaders—especially those who don’t look, talk, or network like the current C‑suite—qui

Executive search firms live with constant peaks and troughs in demand, creating pressure on research teams, margins, and delivery quality. This article explores how flexible research capability—blending strong in‑house teams with trusted external support—can help firms manage volatile workloads, protect consultant time, and maintain consistent standards without over‑hiring or risking burnout.

What the AI Research tells us vs what people are saying! If you read recent scientific reviews on artificial intelligence (AI) in the pharmaceutical industry, you get a clear message: AI is transforming drug discovery, clinical development, manufacturing, and safety.¹⁻⁵ If you talk to bench scientists, clinical teams, or data scientists over coffee, you often hear a more complicated story: pockets of impressive success, a lot of incremental improvements, and quite a few stall

On 23rd July, I’m officially launching Sharon Shields Consulting — a specialist consultancy focused on executive research, market mapping and talent intelligence for life sciences organisations across the UK, Europe and the US. I also partner with executive search consultancies who need deep, reliable research support for complex senior mandates.